Dyspnea News and Research

RSS
Dyspnea or dyspnoea or shortness of breath is a debilitating symptom that is the experience of unpleasant or uncomfortable respiratory sensations.

Further Reading

Interim data from Schering-Plough's narlaprevir Phase IIa study

Interim data from Schering-Plough's narlaprevir Phase IIa study

Study of combination therapy versus monotherapy for pulmonary arterial hypertension

Study of combination therapy versus monotherapy for pulmonary arterial hypertension

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Avicenna's work on respiratory diseases highlighted in SAGE journal

Avicenna's work on respiratory diseases highlighted in SAGE journal

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

King Pharmaceuticals receives exclusive rights to market and sell CYANOKIT

King Pharmaceuticals receives exclusive rights to market and sell CYANOKIT

New data from efficacy study of CIMZIA in Crohn's disease patients presented

New data from efficacy study of CIMZIA in Crohn's disease patients presented

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

King Pharmaceuticals receives FDA complete response letter for CorVue NDA

King Pharmaceuticals receives FDA complete response letter for CorVue NDA

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Bristol-Myers Squibb presents study data on ORENCIA for treating rheumatoid arthritis

Bristol-Myers Squibb presents study data on ORENCIA for treating rheumatoid arthritis

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

Synta Pharmaceuticals updates its Phase 3 SYMMETRY trial results at the Melanoma XIII Conference

Synta Pharmaceuticals updates its Phase 3 SYMMETRY trial results at the Melanoma XIII Conference

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

Schering-Plough receives FDA recommendation approval for PEGINTRON

Schering-Plough receives FDA recommendation approval for PEGINTRON

FOLOTYN available for commercial sale in the United States

FOLOTYN available for commercial sale in the United States

FDA grants Fast Track designation to Corthera's relaxin for treating acute heart failure

FDA grants Fast Track designation to Corthera's relaxin for treating acute heart failure

FDA grants accelerated approval for Allos Therapeutics’ FOLOTYN

FDA grants accelerated approval for Allos Therapeutics’ FOLOTYN